New report sets out clear steps pharma cos to curb AMR risk in antibiotic production EP News Bureau Aug 23, 2023 The report also demonstrates how proactively adopting and scaling responsible manufacturing practices is a critical way for…
Claris settles patent case with Fresenius Kabi over Diprivan generic Usha Sharma Apr 21, 2015 In December 2014, Fresenius Kabi had filed a suit against Claris Lifesciences to block commercialisation of its ANDA for Propofol
